Edition:
United States

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

38.00USD
17 Nov 2017
Change (% chg)

$0.10 (+0.26%)
Prev Close
$37.90
Open
$38.10
Day's High
$38.65
Day's Low
$37.85
Volume
142,076
Avg. Vol
192,530
52-wk High
$50.03
52-wk Low
$20.60

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Charles Newhall

72 2016 Independent Chairman of the Board

Jack Khattar

55 2005 President, Chief Executive Officer, Secretary, Director

Gregory Patrick

65 2011 Chief Financial Officer, Vice President

Stefan Schwabe

65 2012 Executive Vice-President - Research and Development, Chief Medical Officer

Padmanabh Bhatt

59 2012 Senior Vice President - Intellectual Property, Chief Scientific Officer